Answers are grounded in this paper and cite their sources.
-pyridiniummethyl)-4',5'-dihydropsoralens are described. The compounds are potential therapeutic agents for improved psoralen ultraviolet radiation therapy with reduced mutagenicity.
No takes yet. Share an insight, caveat, or question.
Whittemore et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: